Category: Blood Diseases
Global Blood Diseases
-
Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2024-2030
... 4.76 billion in 2023 and expected to reach USD 5.47 billion in 2024, at a CAGR 14.44% to reach USD 12.25 billion by 2030. Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized ... Read More
-
Hemoglobin Testing Market by Type (Blood Glucose Testing, Cyanmethemoglobin Method, Hemoglobin Electrophoresis), Technology (Laboratory Testing, Point-of-Care Testing), Operation, Application, End-User - Global Forecast 2024-2030
... in 2023 and expected to reach USD 6.04 billion in 2024, at a CAGR 6.10% to reach USD 8.63 billion by 2030. The hemoglobin testing market comprises various diagnostic products, services, and technologies that healthcare ... Read More
-
Sickle Cell Anemia Testing & Screening Market by Technology (Hemoglobin Electrophoresis, High-performance Liquid Chromatography (HPLC), Point-of-Care Tests), Age Group (Adult Screening, Newborn Screening, Years 1 to 25), Sector - Global Forecast 2024-2030
... Anemia Testing & Screening Market size was estimated at USD 943.95 million in 2023 and expected to reach USD 1,070.69 million in 2024, at a CAGR 13.51% to reach USD 2,293.22 million by 2030. Sickle ... Read More
-
Sickle Cell Disease Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2031 - By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa)
... Africa) The global sickle cell disease treatment market encounters numerous challenges that impede its revenue growth. These challenges stem from inadequate healthcare infrastructure, unavailability of drugs in rural regions, lack of reimbursement, high treatment costs, ... Read More
-
2024 Global Forecast for Plasma Fractionation Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
Global Rare Hemophilia Factors Databank Market Report
... 2021 to 2029. Factor II segment is expected to be the highest contributor to this market, with $1,123.8 Million in 2020, and is anticipated to reach $1,801.8 Million by 2029, registering a CAGR of 5.44%. ... Read More
-
Global Hematologic Malignancies Databank Market Report
... 2029. Leukemia segment is expected to be the highest contributor to this market, with $13,172.5 Million in 2020, and is anticipated to reach $25,934.9 Million by 2029, registering a CAGR of 7.87%. Lymphoma segment is ... Read More
-
Global Hemophilia Gene Therapy Market Analysis and Forecast 2024-2030
... genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels are injured. Individuals ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood ... Read More
-
Global Hemophilia Gene Therapy Market Size, Manufacturers, Opportunities and Forecast to 2030
... caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and stop bleeding when blood vessels ... Read More
-
Global Hemophilia Gene Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2019-2030
... disease (a disease that is caused by a genetic defect in a single gene). There are two types of hemophilia caused by mutations in genes that encode protein factors which help the blood clot and ... Read More
-
Global Thalassemia Market - 2024-2031
... 2024-2031. Thalassemia represents a substantial health burden, particularly in regions where the prevalence is high. Individuals with severe forms of thalassemia require lifelong medical care, including blood transfusions, iron chelation therapy, and management of complications ... Read More
-
Global chemotherapy-induced thrombocytopenia Market - 2023-2030
... forecast period 2023-2030. Chemotherapy-induced thrombocytopenia (CIT) is characterized by a decreased platelet count in the blood as a result of chemotherapy treatment. Because platelets are necessary for blood clotting, a drop in their number can ... Read More
-
Global Anemia Treatment Drugs Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Anemia Treatment Drugs is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Global Alpha Thalassemia Treatment Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Alpha Thalassemia Treatment is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
-
Acquired Hemophilia Treatment Global Market Report 2024
... Bristol-Myers Squibb Company Acquired Hemophilia Treatment Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market. This report focuses on ... Read More
-
Global Iron Deficiency Anemia Drug Market Growth (Status and Outlook) 2024-2030
... With growing demand in downstream market, the Iron Deficiency Anemia Drug is forecast to a readjusted size of US$ 2372.1 million by 2030 with a CAGR of 5.2% during review period. The research report highlights ... Read More
-
Stem Cell Umbilical Cord Blood Market Size, Trends, Analysis, and Outlook By Storage Serivces (Public Cord Blood Banks, Private Cord Blood Banks, Hybrid Cord Blood Banks), By Therapeutics (Cancer, Diabetes, Blood diseases, Immune Disorders, Metabolic Disorders, Others), By Application (Transplant Medicine, Regenerative Medicine), by Region, Country, Segment, and Companies, 2024-2030
... Disorders, Others), By Application (Transplant Medicine, Regenerative Medicine), by Region, Country, Segment, and Companies, 2024-2030 The global Stem Cell Umbilical Cord Blood market size is poised to register 9.8% growth (CAGR) from 2024 to 2030, ... Read More
-
Biologic Therapeutics Market Size, Trends, Analysis, and Outlook By Product (Vaccines, Blood and Blood Products, Allergenic Extracts, Human Cells and Tissues, Gene Therapies, Proteins, Cellular Therapies, Xenotransplantation Products), By Application (Rheumatoid Arthritis, Anemia, Cancer, Diabetes, Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030
... Others), By Source (Humans, Avian Cell Culture, Yeast, Bacteria, Insects Cell Culture, Transgenics), by Region, Country, Segment, and Companies, 2024-2030 The global Biologic Therapeutics market size is poised to register 7.8% growth (CAGR) from 2024 ... Read More
-
Hemoglobinopathies Treatment Market Size, Trends, Analysis, and Outlook By Treatment (Stem Cell Therapy, Blood Transfusion, Iron Chelation Therapy, Others), By Application (Thalassemia, Sickle Cell Anaemia, Others), by Region, Country, Segment, and Companies, 2024-2030
... Hemoglobinopathies Treatment market size is poised to register 9.1% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Hemoglobinopathies Treatment market By ... Read More
-
Hemophilia Therapeutics Market Size, Trends, Analysis, and Outlook By Type (Hemophilia A, Hemophilia B, Hemophilia C), By Product (Recombinant coagulation factor concentrates therapy, Plasma derived coagulation factor concentrates therapy, Non-factor replacement therapy, Others), By Therapy (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030
... (Replacement Therapy, Gene Therapy, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Hemophilia Therapeutics market size is poised to register 7.38% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies ... Read More
-
Global Diamond–Blackfan Anemia (DBA) Treatment Market - 2024-2031
... YY% during the forecast period 2024-2031. Pure red cell aplasia is the defining feature of Diamond Blackfan anemia (DBA), a congenital form of anemia linked to congenital bone defects. This anemia is persistent macrocytic-normocytic. 40 ... Read More
-
Global Thalassemia Gene Test Kit Supply, Demand and Key Producers, 2024-2030
... during the forecast period (2024-2030). Thalassemia Gene Test Kit is a diagnostic tool used to detect genetic mutations associated with thalassemia, a group of blood disorders that affect hemoglobin production. Hemoglobin is a protein in ... Read More
-
Global Thalassemia Gene Test Kit Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. Thalassemia Gene Test Kit is a diagnostic tool used to detect ... Read More
-
Global Chemotherapy Induced Anemia Market Growth (Status and Outlook) 2024-2030
... in downstream market, the Chemotherapy Induced Anemia is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the ... Read More
Research Assistance
